SCHEMBL190426

SCHEMBL190426

Fc1cccc(F)c1Oc1ccnc(Nc2nc(-c3ccccn3)cs2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN1 Q92952 2/20 0.61
KCNN2 Q9H2S1 2/20 0.61
KCNN3 Q9UGI6 2/20 0.61
SLC2A1 P11166 4/20 0.60
MBD2 Q9UBB5 2/20 0.60
MECP2 P51608 1/20 0.60
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
MAPT P10636 3/20 0.54
NFKB1 P19838 3/20 0.54
NFKB2 Q00653 3/20 0.54
RELA Q04206 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
PPP1CA P62136 2/20 0.54
TP53 P04637 2/20 0.54
ALDH1A1 P00352 1/20 0.54
ALPL P05186 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190602 0.89 NPC1 (0.58) KCNN1KCNN2KCNN3SLC2A1MBD2
SCHEMBL190433 0.87 RAB9A (0.55) KCNN1KCNN2KCNN3SLC2A1MEN1
SCHEMBL191840 0.84 RAB9A (0.47) KCNN1KCNN2KCNN3SLC2A1MBD2
SCHEMBL191394 0.83 RAB9A (0.58) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL191689 0.83 GCK (0.52) KCNN1KCNN2KCNN3SLC2A1MEN1
SCHEMBL24358232 0.83 KCNN1 (0.72) KCNN1KCNN2KCNN3SLC2A1MBD2
SCHEMBL30745759 0.83 KCNN1 (0.72) KCNN1KCNN2KCNN3SLC2A1MBD2
SCHEMBL191008 0.82 GCK (0.46) KCNN1KCNN2KCNN3SLC2A1MBD2
SCHEMBL192191 0.81 GCK (0.47) KCNN1KCNN2KCNN3SLC2A1MEN1
SCHEMBL190863 0.80 GCK (0.49) KCNN1KCNN2KCNN3SLC2A1MBD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 KCNN1 1454/4885KCNN2 1319/4885KCNN3 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.